Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 06/26 | 06/30 | 894,337 sh2 trades | $10.13avg. | $9,059,633.81 | −57.7% | |
James G. Coulter10% Owner | LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 28,281,943 sh | $8.02 | $226,821,182.86 | −20.2% |
Jon Winkelried10% Owner | LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 28,281,943 sh | $8.02 | $226,821,182.86 | −20.2% |
Darren M. BlackDirector | LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 5,899,661 sh | $8.02 | $47,315,281.22 | −20.2% |
Eric ShueyDirector | LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 243,362 sh | $8.02 | $1,951,763.24 | −21.9% |
LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 575,034 sh2 trades | $8.02avg. | $4,611,772.68 | −34.3% | |
TPG GP A10% Owner | LifeStance Health GroupLFST | Open-market sale | 05/12 | 05/14 | 28,281,943 sh | $8.02 | $226,821,182.86 | −20.2% |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 05/07 | 05/11 | 75,000 sh2 trades | $8.55avg. | $641,250 | −5.2% | |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 04/23–04/24 | 04/27 | 69,899 sh4 trades | $7.04avg. | $492,400.35 | −4.8% | |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 04/21 | 04/23 | 5,101 sh2 trades | $7.01avg. | $35,758.01 | −0.4% | |
James G. Coulter10% Owner | LifeStance Health GroupLFST | Open-market sale | 03/02 | 03/04 | 20,685,061 sh | $7.01 | $145,002,277.61 | −12.9% |
Jon Winkelried10% Owner | LifeStance Health GroupLFST | Open-market sale | 03/02 | 03/04 | 20,685,061 sh | $7.01 | $145,002,277.61 | −12.9% |
Darren M. BlackDirector | LifeStance Health GroupLFST | Open-market sale | 03/02 | 03/04 | 4,314,939 sh | $7.01 | $30,247,722.39 | −12.9% |
TPG GP A10% Owner | LifeStance Health GroupLFST | Open-market sale | 03/02 | 03/04 | 20,685,061 sh | $7.01 | $145,002,277.61 | −12.9% |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 25/12/19–25/12/22 | 25/12/23 | 121,643 sh4 trades | $7.04avg. | $856,366.72 | −7.8% | |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 25/12/18 | 25/12/19 | 6,442 sh2 trades | $7.00avg. | $45,094 | −0.4% | |
Ann VaranakisChief People Officer | LifeStance Health GroupLFST | Open-market sale | 25/12/17 | 25/12/19 | 50,000 sh | $6.90 | $345,000 | −13.7% |
LifeStance Health GroupLFST | Open-market sale10b5-1 plan | 25/12/12–25/12/15 | 25/12/16 | 92,001 sh4 trades | $7.01avg. | $644,803.3 | −5.8% | |
Miller Lisa K.SEE REMARKS | LifeStance Health GroupLFST | Open-market sale | 25/11/21 | 25/11/25 | 57,240 sh | $6.43 | $368,053.2 | −18.0% |
Summit Partners10% Owner | LifeStance Health GroupLFST | Open-market sale | 25/08/18 | 25/08/20 | 8,407,643 sh | $5.07 | $42,626,750.01 | −20.1% |